Spatial sampling of breast cancer cell populations revealed a divergent profile of DNA methylation across the tumour that is mainly detected at genes such as GSTP1, FOXC1, ABCB1, PTEN, and TGM2 that contribute to drug resistance. This evidence concerns the gene PTEN and neoplasm.